Home / Cancer and immune system / Gemcitabine
ATC L01BC05 · Antineoplastic Agents
Gemcitabine shortage
As of 31 Oct 2026, Gemcitabine has a reported shortage in 4 of the 5 countries we track (Germany, Italy, Spain, Belgium), covering 13 products.
Countries4/5
Products13packs or presentations
Short since4 Dec 20232.9 years ago
Earliest return31 Oct 2026company estimate
No return date7products
Main reasonManufacturing problem
Timeline
GermanyItalySpainBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Bendacitabin 38 mg/ml | BENDALIS GmbH | 4 Dec 2023 | 31 Jan 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Bendacitabin 38 mg/ml | BENDALIS GmbH | 4 Dec 2023 | 31 Jan 2027 | Manufacturing problem Probleme in der Herstellung |
| DE | Bendacitabin 38 mg/ml | BENDALIS GmbH | 4 Dec 2023 | 31 Jan 2027 | Manufacturing problem Probleme in der Herstellung |
| IT | GEMCITABINA SUN PHARMA | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 5 Jan 2024 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | GEMCITABINA SUN PHARMA | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 12 May 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | GEMCITABINA SUN PHARMA | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 30 Jun 2024 | not given | Manufacturing problem Problemi produttivi |
| IT | GEMCITABINA SUN PHARMA | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 20 May 2025 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | SOLGEKMA | HIKMA FARMACEUTICA (PORTUGAL) S.A. | 5 Aug 2026 | 31 Oct 2026 | Increased demand Elevata richiesta |
| IT | GEMCITABINA SUN PHARMA | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 4 Sep 2026 | not given | Manufacturing problem Problemi produttivi |
| IT | GEMCITABINA ACCORD announced | ACCORD HEALTHCARE, S.L.U. | 27 Nov 2026 | not given | Increased demand Elevata richiesta |
| IT | GEMSOL announced | SANDOZ S.P.A. | 15 Dec 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | GEMCITABINA ACCORD 1500 mg CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 15 ml | Accord Healthcare S.L.U. | 6 Oct 2024 | 29 Nov 2026 | Not stated |
| BE | Gemcitabine Accord Healthcare 100 mg/ml inf. sol. (conc.) i.v. vial 15 ml | Accord Healthcare | 17 Jul 2025 | 30 Dec 2026 | Manufacturing problem Delay in production |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.